BIOFRONTERA AG (B8FK.DE) Stock Earnings & Estimates
Europe - FRA:B8FK - DE000A4BGGM7 - Common Stock
2.67 EUR
0 (0%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | ||
|---|---|---|---|---|---|
| Revenue YoY % growth | 25.738M -10.59% | 32.249M 25.30% | 21.666M -32.82% | 52.094M 140.44% | |
| EBITDA YoY % growth | 2.248M 119.51% | 5.878M 161.48% | -4.677M -179.57% | 10.404M 322.45% | |
| EBIT YoY % growth | 1.502M 110.14% | 5.088M 238.75% | -5.517M -208.43% | 9.996M 281.19% | |
| Operating Margin | 5.84% | 15.78% | -25.46% | 19.19% | |
| EPS YoY % growth | N/A -9.16% | N/A 100.69% | N/A -4.34% | 0.11 124.55% |
All data in EUR
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in EUR
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2022 Q2Q % growth | -5.83 -455.55% | -1.07 | -4.76 | -444.65% |
| Q3 2021 Q2Q % growth | -1.17 16.67% | -2.38 | 1.21 | 50.98% |
| Q2 2021 Q2Q % growth | -0.82 -450.01% | -1.43 | 0.61 | 42.81% |
| Q1 2021 Q2Q % growth | -1.05 35.71% | -1.43 | 0.38 | 26.47% |
| Q4 2020 Q2Q % growth | 0.00 100.00% | -0.48 | 0.48 | 100.00% |
| Q3 2020 Q2Q % growth | -1.40 52.00% | -1.67 | 0.27 | 15.97% |
| Q2 2020 Q2Q % growth | 0.23 -92.31% | -0.24 | 0.47 | 198.05% |
| Q1 2020 Q2Q % growth | -1.63 -133.33% | -1.31 | -0.32 | -24.78% |
| Q4 2019 Q2Q % growth | -1.17 | -0.48 | -0.69 | -145.07% |
| Q3 2019 Q2Q % growth | -2.92 | -1.90 | -1.01 | -53.19% |
| Q2 2019 Q2Q % growth | 3.03 | -1.19 | 4.22 | 354.91% |
| Q1 2019 Q2Q % growth | -0.70 | -1.19 | 0.49 | 41.17% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 2.99M -14.40% | % | ||
| Q1 2025 Q2Q % growth | 5.768M 55.35% | % | ||
| Q4 2024 Q2Q % growth | 10.942M 46.87% | % | ||
| Q3 2024 Q2Q % growth | 3.518M -49.85% | % | ||
| Q1 2022 Q2Q % growth | 73.21% | 9.894M | % | |
| Q3 2021 Q2Q % growth | 27.45% | 6.63M | % | |
| Q2 2021 Q2Q % growth | 100.00% | 5.712M | % | |
| Q1 2021 Q2Q % growth | -13.85% | 5.712M | % | |
| Q4 2020 Q2Q % growth | -21.31% | 9.792M | % | |
| Q3 2020 Q2Q % growth | -1.92% | 5.202M | % | |
| Q2 2020 Q2Q % growth | -60.00% | 2.856M | % | |
| Q1 2020 Q2Q % growth | -4.41% | 6.63M | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | 0% | 0% |
| Revenue | N/A | N/A | 0% | 0% |